Related Experiment Video
Updated: Jul 4, 2026

A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
Clinical features and risk factors for HIV encephalopathy in children
M Z A Hamid1, N A Aziz, Z Syed Zulkifli
1Department of Pediatrics, Faculty of Medicine and Health, Universiti Putra Malaysia, Serdang, Selangor. zaini@medic.upm.edu.my
Insights
Progressive encephalopathy (PE) affected 18.2% of children with HIV in Malaysia. Lower CD4 counts and percentages were linked to PE development in this pediatric cohort.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroimmunology
Background:
- Human Immunodeficiency Virus (HIV) infection can lead to neurological complications in children.
- Progressive encephalopathy (PE) is a serious neurodevelopmental disorder associated with HIV/AIDS.
- Understanding the incidence and clinical features of PE in pediatric HIV cohorts is crucial for early diagnosis and management.
Purpose of the Study:
- To determine the incidence of progressive encephalopathy (PE) in children with HIV.
- To identify clinical manifestations and associated factors of PE in this cohort.
- To assess the relationship between immunological markers (CD4 counts, CD4 percentages) and PE.
Main Methods:
- Prospective cohort study of 55 children with HIV over 24 months.
- Regular neurological, neurobehavioral, and immunological assessments (CD4, viral load, IQ).
- Diagnosis of PE based on established criteria from the Consensus of Pediatric Neurology/Psychology Working Group.
Main Results:
- The incidence of PE was 18.2% (10 out of 55 children) in 2002.
- Common clinical signs included hepatosplenomegaly, lymphadenopathy, and abnormal deep tendon reflexes.
- Five patients exhibited impaired brain growth; lower CD4 counts and percentages were significantly associated with PE.
Conclusions:
- Progressive encephalopathy is a significant concern in pediatric HIV infection.
- Immunological status, particularly CD4 cell counts and percentages, is strongly associated with the development of PE.
- Regular neurological monitoring and assessment of immunological markers are essential for managing HIV-infected children at risk for PE.
Abstract:
A prospective cohort study was conducted to determine the incidence of progressive encephalopathy (PE) and its associated clinical manifestations amongst a cohort of HIV infected children attending the HIV/AIDS clinic of the Pediatric Institute, Kuala Lumpur Hospital, Malaysia. Neurological and neurobehavioral assessments were performed in 55 children with HIV over a 24-month study period. Parameters assessed were physical and neurological assessments, CD4 counts, CD4 percentages, RNA viral loads and an IQ assessment at four monthly intervals. PE was diagnosed when patient developed at least one of the definitive criteria for PE based on the Consensus of Pediatric Neurology/Psychology Working Group, AIDS Clinical Trial 1996. The incidence of encephalopathy was 18.2% (n = 10) in 2002. All the patients had hepatosplenomegaly, lymphadenopathy, abnormal deep tendon reflexes and five had impairment in brain growth. The CD4 counts and CD4 percentages were more likely to be associated with PE compared to the non-PE group.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cryptococcal Meningitis
Hepatic Encephalopathy
Arboviral Encephalitis
Huntington Disease l: Introduction

